Company Profile
Bukwang Pharmaceutical develops, produces, and sells pharmaceutical products in South Korea and globally. It offers its products in oral solid dosage forms, injections, oral solutions, external solutions, and ointments, as well as ethical drugs Including drugs for treating diabetic peripheral neuropathy, hypothyroidism, toxic liver disease, chronic hepatitis, liver cirrhosis, and iron-deficiency anemia.
Its portfolio also includes over-the-counter drugs, such as fever and pain relief medication, gastrointestinal medication, cold medication, laxatives for constipation, collagen supplements, multivitamin supplements, mouthwash, topical gels, oral health supplements, and omega-3 supplements, personal products comprising toothpastes, toothbrushes, and oral care products, nutraceuticals, health functional foods, and quasi drugs.
Additionally, it offers products for various threptic areas, including endocrinology, gastroenterology, cardiology, oncology, central nervous system, iron supplements, neuropsychiatry, respiratory/allergy, dermatology, urology, and treatment areas. It also's development pipeline comprises Lurasidone for the treatment of schizophrenia and bipolar depression.
Its portfolio also includes JM-010, for treating dyskinesia in parkinson's disease, SOL-804, which is used for the treatment of metastatic castration resistant prostate cancer, AhR Inhibitor for solid tumors, PKR Inhibitor for neurodegenerative disorders, and PD Program for parkinson's disease. Founded in 1960, Bukwang Pharmaceutical is headquartered in Seoul, South Korea.